Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.
By D. Ratnam, D. Ankola, V. Bhardwaj, D. Sahana, M.N.V. Ravi Kumar. Journal of Controlled Release, 2006
875 citations recorded by the source corpus.
Subfields: Biochemistry, Endocrinology, Diabetes and Metabolism, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/97d277f328d6e375bdb98ebc7a0a324d552bab02
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biochemistry
In Molecular Biology
Citations in the corpus
- A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. (2013, background): “Some of the most important flavonoids are catechin, catechin-gallate, quercetin and kaempferol (Rice-Evans et al., 1996; Procházková et al., 2011).”
- Bioavailability of nanoparticles in nutrient and nutraceutical delivery (2009, background): “have proposed the use of nanoparticle delivery systems for the delivery of more polar compounds such as isoflavones, and suggested that micro- and nanoparticles are among the most promising systems to accomplish this objective [92].”
- Exogenous antioxidants—Double-edged swords in cellular redox state (2010, background): “Our antioxidant defense system includes endogenous (enzymatic and non-enzymatic) antioxidants such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione (GSH), among others and exogenous antioxidants such as vitamin C, vitamin E, carotenoids and polyphenols, wit”